Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026)
Ufp Technologies (UFPT) posted Net Income towards Common Stockholders of $17.5 million for Q1 2026, little changed on a QoQ basis from $17.6 million in Q4 2025, and up 1.81% year-over-year from $17.2 million in Q1 2025.
Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Ufp Technologies' Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $17.5 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 1.81% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.6 million (up 8.12% YoY) and the FY2025 annual result came in at $68.3 million, up 15.82% from the prior year.
- Net Income towards Common Stockholders was $17.5 million for Q1 2026 at Ufp Technologies, roughly flat from $17.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $19.5 million in Q3 2022 and bottomed at $4.9 million in Q1 2022.
- A 5-year average of $13.6 million and a median of $13.6 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 415.7% — and 2023, when it slumped 40.15%.
- Ufp Technologies' Net Income towards Common Stockholders stood at $8.5 million in 2022, then surged by 37.17% to $11.6 million in 2023, then soared by 41.08% to $16.4 million in 2024, then gained by 7.27% to $17.6 million in 2025, then fell by 0.4% to $17.5 million in 2026.
- Business Quant data shows UFPT's Net Income towards Common Stockholders at $17.5 million in Q1 2026, $17.6 million in Q4 2025, and $16.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Ufp Technologies | 1.92 Bn | 1.90 Bn | 44.36 Mn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.72 Mn |